Standard BioTools Inc
NASDAQ:LAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Standard BioTools Inc
NASDAQ:LAB
|
US |
|
D
|
Digital Invest eV AG
F:ENGL
|
DE |
|
A
|
Advanced Information Technology Public Company Limited
SET:AIT
|
TH |
|
K
|
Kancera AB
F:3EE0
|
SE |
|
Surface Transforms PLC
LSE:SCE
|
UK |
|
F
|
FAE Technology SpA SB
MIL:FAE
|
IT |
Wall St Price Targets
LAB Price Targets Summary
Standard BioTools Inc
According to Wall Street analysts, the average 1-year price target for LAB is 1.581 USD with a low forecast of 1.3635 USD and a high forecast of 1.8375 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LAB's stock price target?
Price Target
1.581
USD
According to Wall Street analysts, the average 1-year price target for LAB is 1.581 USD with a low forecast of 1.3635 USD and a high forecast of 1.8375 USD.
What is the Revenue forecast for Standard BioTools Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 1%.
What is the Gross Profit forecast for Standard BioTools Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 4 years is 4%.
